Sleep and stress management is one of the newest categories in peptide research. It includes FDA-approved neuropeptides with established medical uses (vasopressin, oxytocin), Russian-developed anxiolytic peptides (Selank, Semax), and research compounds like DSIP (Delta Sleep-Inducing Peptide) that have been studied for decades with inconsistent results. This reference profiles 19 peptides and compounds studied for sleep regulation, stress response, and anxiety. Each is ranked by scientific evidence strength, with FDA status clearly marked.
Important: Star ratings measure evidence strength, not safety.
Every compound in this category, ranked by evidence strength.
| Peptide | FDA Status | Evidence | Key Note |
|---|---|---|---|
| Vasopressin (AVP) | FDA-Approved (specific medical uses) | ★★★☆☆ | Sleep/stress application not the approved indication |
| Oxytocin | FDA-Approved (prescription) | ★★★☆☆ | Meaningful human data for stress/anxiety; sleep claims more limited |
| Thymosin Alpha-1 | Approved in 35+ countries / Research in US | ★★★☆☆ | Strong immune evidence; stress application emerging |
| Semax | Approved in Russia / Research in US | ★★★☆☆ | Published human data; primarily Russian literature |
| Selank | Approved in Russia / Research in US | ★★★☆☆ | Published human anxiolytic data; primarily Russian literature |
| VIP (CIRS / sleep) | Research / Compounding | ★★★☆☆ | Shoemaker CIRS protocol has human data; general sleep claims more limited |
| Epithalon | Research | ★★★☆☆ | Some human sleep/circadian data in Russian literature |
| Pinealon | Research | ★★☆☆☆ | Primarily Russian preclinical literature |
| DSIP (Delta Sleep-Inducing Peptide) | Research | ★★☆☆☆ | Human studies exist but results are inconsistent |
| Ghrelin | Research | ★★☆☆☆ | Some human GH/sleep data; stress-specific claims preclinical |
| KPV | Research | ★★☆☆☆ | Primarily preclinical anti-inflammatory data |
| Neuropeptide Y (NPY) | Research | ★★☆☆☆ | Some human stress/anxiety data; mostly preclinical |
| Cortistatin | Research | ★★☆☆☆ | Primarily preclinical |
| Galanin | Research | ★★☆☆☆ | Primarily preclinical sleep data |
| CRF / CRH Analogs | Research | ★★☆☆☆ | Used as research tools; not therapeutic compounds |
| Urocortin Peptides | Research | ★★☆☆☆ | Primarily preclinical |
| ACTH (4-10) | Research | ★★☆☆☆ | Some human cognitive/stress data; limited |
| Melanocyte-Inhibiting Factor (MIF-1) | Research | ★★☆☆☆ | Primarily preclinical |
| Tyr-MIF-1 | Research | ★☆☆☆☆ | Mechanistic/early research only |
An anxiolytic (anti-anxiety) peptide with published human data on stress reduction. Approved in Russia; research-only in the US. Related to Semax but with a stronger anxiolytic profile.
Studied for both cognitive enhancement and stress response. Published human data, primarily Russian literature. May have stress-modulating effects alongside its cognitive profile.
FDA-approved for specific medical uses (diabetes insipidus, shock) at ★★★☆☆. Sleep-specific applications have weaker evidence (★★☆☆☆). An example of a peptide with strong approved-use evidence but limited sleep/stress evidence.
Some human sleep and circadian rhythm data in Russian literature, alongside its longevity research. May affect melatonin production and sleep cycles.
Every compound in this category, fully profiled with mechanisms, evidence ratings, FDA status, and research citations.
Get the Sleep & Stress Management Guide, $19.99 →One-time purchase. Instant download. No subscription.